Results 301 to 310 of about 821,521 (329)

Within-Person Fluctuations in Momentary Loneliness Among People with Schizophrenia. [PDF]

open access: yesInt J Soc Psychiatry
Gentry MM   +7 more
europepmc   +1 more source
Some of the next articles are maybe not open access.

Related searches:

Schizophrenia

The Lancet, 1999
Schizophrenia is among the most severe and debilitating of psychiatric disorders. Diagnosis is currently by criterion-based systems, including positive (eg, hallucinations and delusions) and negative (eg, avolition and alogia) symptoms. The importance of negative symptoms in the course and outcome of the illness is increasingly being studied.
S K, Schultz, N C, Andreasen
openaire   +4 more sources

Schizophrenia

Evidence Based Mental Health, 2004
Schizophrenia is a mental illness that is among the world's top ten causes of long-term disability. The symptoms of schizophrenia include psychosis, apathy and withdrawal, and cognitive impairment, which lead to problems in social and occupational functioning, and self-care.
Zia, Nadeem   +2 more
  +11 more sources

Schizophrenia

Psychiatric Clinics of North America, 1992
Schizophrenia occurring in childhood and adolescence has similar diagnostic, prognostic, and treatment ramifications as those noted with adult-onset schizophrenia. In assessing a child or adolescent suspected of having schizophrenia, care must be given to document DSM-III-R diagnostic criteria within the developmental framework of the patient's ...
J M, McClellan, J S, Werry
openaire   +2 more sources

SCHIZOPHRENIA

Medical Clinics of North America, 2001
To provide the most effective care for this difficult patient population, it is helpful to remember that patients with schizophrenia have disease-intrinsic limitations that limit their ability to participate in their care. These limitations are symptoms of a disease and not volitional.
D C, Goff, S, Heckers, O, Freudenreich
openaire   +2 more sources

Schizophrenia

The Lancet, 2009
Schizophrenia is still one of the most mysterious and costliest mental disorders in terms of human suffering and societal expenditure. Here, we focus on the key developments in biology, epidemiology, and pharmacology of schizophrenia and provide a syndromal framework in which these aspects can be understood together.
Jim, van Os, Shitij, Kapur
openaire   +4 more sources

Schizophrenia

Perspectives on Psychological Science, 2008
Theoretical conceptualizations of schizophrenia have undergone significant change in the past century. Through the application of behavioral science methodology, psychologists have played a major role in the pivotal scientific advances that have led us to contemporary models.
Elaine, Walker, Kevin, Tessner
openaire   +2 more sources

Schizophrenia

Psychiatric Clinics of North America, 1993
The pharmacologic treatment of the schizophrenic patient has remained substantively unchanged during the last 35 years. It is evident that as our knowledge of neuropharmacology has grown--the notion of schizophrenia being merely caused by a hyperdopaminergic state may be too simplistic.
S R, Marder   +3 more
openaire   +2 more sources

Polypharmacy in schizophrenia

Current Opinion in Psychiatry, 2010
Although most guidelines recommend monotherapy in schizophrenia, the combined application of multiple psychotropic agents is very common, especially in treatment-refractory cases. We review the empirical basis supporting these attempts and their relevance for clinical practice.Polypharmacy intends to address different aspects of treatment resistance ...
M, Zink   +2 more
openaire   +3 more sources

Home - About - Disclaimer - Privacy